Media coverage about BIO-key International (NASDAQ:BKYI) has trended positive this week, Accern reports. Accern rates the sentiment of media coverage by reviewing more than 20 million blog and news sources in real-time. Accern ranks coverage of publicly-traded companies on a scale of negative one to positive one, with scores nearest to one being the most favorable. BIO-key International earned a media sentiment score of 0.34 on Accern’s scale. Accern also assigned press coverage about the technology company an impact score of 44.7953739047552 out of 100, indicating that recent media coverage is somewhat unlikely to have an effect on the company’s share price in the immediate future.

Separately, Maxim Group reissued a “buy” rating and issued a $5.50 target price on shares of BIO-key International in a report on Thursday, December 21st.

Shares of BIO-key International (NASDAQ:BKYI) traded down $0.01 on Friday, hitting $1.98. The stock had a trading volume of 15,116 shares, compared to its average volume of 32,346. BIO-key International has a fifty-two week low of $1.20 and a fifty-two week high of $3.67.

BIO-key International (NASDAQ:BKYI) last posted its quarterly earnings data on Tuesday, November 14th. The technology company reported ($0.28) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.17) by ($0.11). BIO-key International had a negative return on equity of 37.54% and a negative net margin of 106.55%. The firm had revenue of $0.94 million for the quarter.

COPYRIGHT VIOLATION WARNING: “BIO-key International (BKYI) Earning Favorable Press Coverage, Study Shows” was posted by Watch List News and is the property of of Watch List News. If you are accessing this story on another site, it was illegally copied and republished in violation of international copyright law. The correct version of this story can be accessed at https://www.watchlistnews.com/bio-key-international-bkyi-earning-favorable-press-coverage-study-shows/1814419.html.

About BIO-key International

BIO-key International, Inc develops and markets fingerprint biometric identification and identity verification technologies, cryptographic authentication-transaction security technologies, as well as related identity management and credentialing software solutions. The Company is also engaged in developing automated, finger identification technology that supplements or compliments other methods of identification and verification, such as personal inspection identification, passwords, tokens, smart cards, identity cards, public key infrastructure (PKI), credit card, passports, driver’s licenses, one-time password (OTP) or other form of possession or knowledge-based credentialing.

Insider Buying and Selling by Quarter for BIO-key International (NASDAQ:BKYI)

Receive News & Ratings for BIO-key International Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for BIO-key International and related companies with MarketBeat.com's FREE daily email newsletter.